Literature DB >> 24572853

Determining the Michigan Hand Outcomes Questionnaire minimal clinically important difference by means of three methods.

Daniel A London1, Jeffrey G Stepan, Ryan P Calfee.   

Abstract

BACKGROUND: To interpret patient-rated outcome measures, clinicians rely on the minimal clinically important difference. The authors studied the range of minimal clinically important difference scores for the overall Michigan Hand Outcomes Questionnaire score its and subscales in a population with various diagnoses and treatments.
METHODS: Patients with a single, unilateral, atraumatic hand/forearm diagnosis completed the Michigan Hand Outcomes Questionnaire before treatment and at 4 ± 1 weeks and 12 ± 2 weeks after treatment. Three methods were used to calculate the minimal clinically important difference: two anchor question methods based on satisfaction (mean change and receiver operating characteristic) and a statistical distribution method.
RESULTS: One hundred eighty-six patients were enrolled, with a baseline median overall questionnaire score of 60.7. Using the mean change method, a minimal clinically important difference of 13 was calculated for the overall questionnaire score. Using a receiver operating characteristic curve (0.8 effect size), the minimal clinically important difference was 9, with an area under the curve of 0.92. When receiver operating characteristic analysis was based on dichotomization of reported satisfaction, the minimal clinically important difference was 12, with an area under the curve of 0.85. Calculating the difference by statistical distribution gave a value of 8. For the subscales, by all methods, triangulated minimal clinically important difference estimates ranged from 10.9 to 14.4.
CONCLUSIONS: The minimal clinically important difference for the overall Michigan Hand Outcomes Questionnaire score in atraumatic hand/forearm conditions falls between 8 and 13. Multiple analytic methods produce nonidentical but similar minimal clinically important differences. The authors recommend using difference estimates in these ranges when planning a clinical trial to investigate hand/forearm function across a range of diagnoses and treatments.

Entities:  

Mesh:

Year:  2014        PMID: 24572853     DOI: 10.1097/PRS.0000000000000034

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  17 in total

1.  Patients With Thumb-base Osteoarthritis Scheduled for Surgery Have More Symptoms, Worse Psychological Profile, and Higher Expectations Than Nonsurgical Counterparts: A Large Cohort Analysis.

Authors:  Robbert M Wouters; Ana-Maria Vranceanu; Harm P Slijper; Guus M Vermeulen; Mark J W van der Oest; Ruud W Selles; Jarry T Porsius
Journal:  Clin Orthop Relat Res       Date:  2019-12       Impact factor: 4.176

2.  What Is the Impact of Comorbidities on Self-rated Hand Function in Patients With Symptomatic Trapeziometacarpal Arthritis?

Authors:  Ryan Calfee; Jennifer Chu; Amelia Sorensen; Erin Martens; John Elfar
Journal:  Clin Orthop Relat Res       Date:  2015-11       Impact factor: 4.176

3.  Minimal Clinically Important Difference After Carpal Tunnel Release Using the PROMIS Platform.

Authors:  Nikolas H Kazmers; Man Hung; Jerry Bounsanga; Maren W Voss; Abby Howenstein; Andrew R Tyser
Journal:  J Hand Surg Am       Date:  2019-05-06       Impact factor: 2.230

4.  Efficacy of combined hand exercise intervention in patients with chemotherapy-induced peripheral neuropathy: a pilot randomized controlled trial.

Authors:  Yuta Ikio; Akira Sagari; Akira Nakashima; Daiki Matsuda; Terumitsu Sawai; Toshio Higashi
Journal:  Support Care Cancer       Date:  2022-02-21       Impact factor: 3.603

5.  Joint Distraction for Thumb Carpometacarpal Osteoarthritis: 2-Year Follow-up Results of 20 Patients.

Authors:  Janna S E Ottenhoff; Anne J Spaans; Assa Braakenburg; Teun Teunis; L Paul van Minnen; Aebele B Mink van der Molen
Journal:  J Wrist Surg       Date:  2021-05-04

6.  Revision Ligament Reconstruction Tendon Interposition for Trapeziometacarpal Arthritis: A Case-Control Investigation.

Authors:  Anita Sadhu; Ryan P Calfee; Andre Guthrie; Lindley B Wall
Journal:  J Hand Surg Am       Date:  2016-10-15       Impact factor: 2.230

7.  Translation, cross-cultural and construct validity of the Dutch-Flemish PROMIS® upper extremity item bank v2.0.

Authors:  Erik-Jan A Haan; Caroline B Terwee; Marieke F Van Wier; Nienke W Willigenburg; Derek F P Van Deurzen; Martijn F Pisters; Aaron J Kaat; Leo D Roorda
Journal:  Qual Life Res       Date:  2020-01-01       Impact factor: 4.147

8.  Concurrent validity and precision of the thumb disability examination (TDX) in first carpometacarpal osteoarthritis.

Authors:  Leah Johnson; Ryan Karau; Corey McGee
Journal:  J Hand Ther       Date:  2021-09-22       Impact factor: 1.950

9.  Machine Learning Can be Used to Predict Function but Not Pain After Surgery for Thumb Carpometacarpal Osteoarthritis.

Authors:  Nina L Loos; Lisa Hoogendam; J Sebastiaan Souer; Harm P Slijper; Eleni-Rosalina Andrinopoulou; Michel W Coppieters; Ruud W Selles
Journal:  Clin Orthop Relat Res       Date:  2022-01-18       Impact factor: 4.755

10.  The Minimal Clinically Important Difference for PROMIS Physical Function in Patients With Thumb Carpometacarpal Arthritis.

Authors:  Daniel J Lee; Ryan P Calfee
Journal:  Hand (N Y)       Date:  2019-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.